Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

PDE IV inhibitors/cytokine inhibitors disclosed by Janssen

Dec. 4, 1996

Bronchoselective beta-adrenergic agonists reported by Almirall

Dec. 4, 1996

Pulmozyme cleared for advanced CF

Dec. 3, 1996

RPR claims dual-action TNF/cAMP phosphodiesterase inhibitors

Dec. 3, 1996

Dual-action PDE IV/TNF-alpha inhibitors reported by Janssen

Dec. 2, 1996

Canadian scientists identify new target for respiratory drugs

Nov. 28, 1996

PDE IV inhibitors reported by E. Merck

Nov. 28, 1996

New NO inhibitors disclosed by Fujisawa

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...